Ampicillin Plus Ceftriaxone Is as Effective as Ampicillin Plus Gentamicin for TreatingEnterococcus faecalisInfective Endocarditis
about
A comparison of different antibiotic regimens for the treatment of infective endocarditisVancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal managementManaging infective endocarditis in the elderly: new issues for an old disease.Resistance Mechanisms, Epidemiology, and Approaches to Screening for Vancomycin-Resistant Enterococcus in the Health Care SettingSafety and efficacy of commonly used antimicrobial agents in the treatment of enterococcal infections: a review.β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.Antimicrobial shortages: Another hurdle for cliniciansMechanisms of antibiotic resistance in enterococci.Infective endocarditis in Ethiopian children: a hospital based review of cases in Addis AbabaLoss of Antibiotic Tolerance in Sod-Deficient Mutants Is Dependent on the Energy Source and Arginine Catabolism in Enterococci.β-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.The fibronectin-binding protein EfbA contributes to pathogenesis and protects against infective endocarditis caused by Enterococcus faecalisAmpicillin in Combination with Ceftaroline, Cefepime, or Ceftriaxone Demonstrates Equivalent Activities in a High-Inoculum Enterococcus faecalis Infection Model.Cefazolin and Ertapenem, a Synergistic Combination Used To Clear Persistent Staphylococcus aureus Bacteremiaβ-Lactams enhance vancomycin activity against methicillin-resistant Staphylococcus aureus bacteremia compared to vancomycin alone.Enterococcus faecalis infective endocarditis: focus on clinical aspects.Aminoglycoside-induced nephrotoxicity--a focus on monitoring: a review of literature.Vancomycin-resistant enterococcal bacteremia pharmacotherapy.Enterococcal endocarditis revisited.Combination antibiotic therapy for the treatment of infective endocarditis due to enterococci.Efficacy of Telavancin Alone and in Combination with Ampicillin in a Rat Model of Enterococcus faecalis Endocarditis.Combination of Ceftriaxone and Ampicillin for the Treatment of Enterococcal Endocarditis: A Qualitative Systematic Review.Role of Combination Antimicrobial Therapy for Vancomycin-Resistant Enterococcus faecium Infections: Review of the Current Evidence.Drug-induced liver injury associated with high-dose ceftriaxone: a retrospective cohort study adjusted for the propensity score.Successful salvage treatment of native valve Enterococcus faecalis infective endocarditis with telavancin: two case reports.Risk factors for acute kidney injury associated with the treatment of bacterial endocarditis at a tertiary academic medical center.Broad-range PCR for early diagnosis of nosocomial Enterococcus gallinarum meningitis.2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the EurWhat's New in the Treatment of Enterococcal Endocarditis?Pharmacodynamics of Ceftaroline plus Ampicillin against Enterococcus faecalis in an In Vitro Pharmacokinetic/Pharmacodynamic Model of Simulated Endocardial Vegetations.My paper 10 years later: infective endocarditis in the intensive care unit.Endocarditis caused by resistant enterococcus: an overview.Contemporary drug treatment of infective endocarditis.New Guidelines Endorse Old Recommendations for Invasive Enterococcal Infections.Postpartum infective endocarditis with Enterococcus faecalis in Japan: a case report.Outpatient parenteral antimicrobial therapy in Enterococcus faecalis infective endocarditis.Mycobacterium abscessus l,d-Transpeptidases Are Susceptible to Inactivation by Carbapenems and Cephalosporins but Not Penicillins.Listeria monocytogenes endocarditis: case report, review of the literature, and laboratory evaluation of potential novel antibiotic synergies.Infective Endocarditis.Structural and Regulatory Changes in PBP4 Trigger Decreased β-Lactam Susceptibility in Enterococcus faecalis.
P2860
Q24185887-C4779878-2C53-47EC-B2EF-BC6B50F281D5Q26798630-41E364BE-0574-4CBB-A91D-7F19AE2363D9Q30245399-7810A241-AEC0-408B-AE20-905A7A4FD926Q30251425-54E4040D-AA2F-475A-8FEA-69FEB8E2A418Q34503844-12F762B1-442B-43E8-8675-9144E181A84EQ35385108-40764FE2-4509-428C-A7DC-2F78D75EA34BQ35569872-26F4E1CD-91A8-4BDC-9E0C-6CAF368C6930Q35610646-D5875A1B-2ED0-481B-9B5D-3ABA7B1654C6Q35668317-9DDD20D3-214C-46C5-A9C8-13F0AB16EFA0Q35741895-6CE53182-0BE1-48C7-90F2-45FE8126F029Q35974360-584D7403-E86F-40E0-85E7-EC35A0468D96Q36281265-90E61ABC-7659-4A0C-BC81-9CAFCA443851Q36887732-6983D275-85A0-45DD-8121-656652904800Q37358638-B4562A07-2E75-42F0-8F22-32F9F4CD2D01Q37544579-35F5E073-7399-4B17-9B3F-9ED9D85CF543Q38145269-BBA3B4B9-9BC9-4DD6-9B78-101575D4B0A8Q38239999-D7B34CC5-8737-47E5-9B18-FB4E92E127BCQ38263421-A038DFC5-6487-4F53-B896-9FDCBC542825Q38539279-2D721853-1EC1-41D9-90A2-70EE0BFCD31DQ38577676-DF9B0810-35A0-4FB5-89CE-14A921C1F0F6Q38892614-B403683F-9C74-41C9-8DAA-2C67439CD02BQ38976130-2752CBCA-1D80-4D16-AEED-5F6D6D90F6CBQ39168565-7337B11D-A92C-4721-B907-4E4CD50B6D42Q39812362-A772BA8A-53CF-475A-9A30-385604F3C966Q40294018-99E1654D-E85F-41C2-B70B-288723635AFBQ40314153-9D3BB8CA-3EA7-436C-980C-09A524D791F6Q40706631-422C3E4E-46ED-4072-8614-E76BB72EA52EQ41026009-C4159179-49B0-48AE-ADB1-8EF12F128F26Q41368979-AD732342-4F37-4015-8042-B6DC5C1A6AE7Q41695361-D5E648A5-91D6-4118-B4A9-E3DC09DC5D57Q41732633-D54F5E09-4F94-48F4-9648-570DD4991C24Q42259672-FC8650C7-6AA4-466A-AD10-5BA8AC5CC0EFQ42264366-C3C490DA-30D4-4A51-8EF8-3F656938DF26Q43430678-1D7C1B99-1C86-4D14-8111-1205A94FEC0AQ46062457-48E86D1E-837B-4CBA-AF0A-FA2013992A55Q47654438-E3218AED-EC22-4C61-910F-323940683B04Q48318081-99562A68-8851-47B5-9D87-FF22651E02C8Q48536246-46354623-DAC2-4113-8FAB-A0C163BE6BDCQ51024411-7967F2BD-B458-4701-8AA0-8F2F50E602FAQ52609083-306A3D9D-52B8-401F-81B4-3FC8F51CDF96
P2860
Ampicillin Plus Ceftriaxone Is as Effective as Ampicillin Plus Gentamicin for TreatingEnterococcus faecalisInfective Endocarditis
description
im Februar 2013 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2013
@uk
name
Ampicillin Plus Ceftriaxone Is ...... faecalisInfective Endocarditis
@en
Ampicillin Plus Ceftriaxone Is ...... faecalisInfective Endocarditis
@nl
type
label
Ampicillin Plus Ceftriaxone Is ...... faecalisInfective Endocarditis
@en
Ampicillin Plus Ceftriaxone Is ...... faecalisInfective Endocarditis
@nl
prefLabel
Ampicillin Plus Ceftriaxone Is ...... faecalisInfective Endocarditis
@en
Ampicillin Plus Ceftriaxone Is ...... faecalisInfective Endocarditis
@nl
P2093
P2860
P50
P356
P1476
Ampicillin Plus Ceftriaxone Is ...... faecalisInfective Endocarditis
@en
P2093
Albert Pahissa
Antonio Plata
Arístides de Alarcón
Carmen Hidalgo-Tenorio
Carmen Peña
Carmen Sáez
Isidre Vilacosta
Javier López
Javier de la Torre
Joan Gavaldà
P2860
P304
P356
10.1093/CID/CIT052
P407
P577
2013-02-07T00:00:00Z